ExoSphere provides a microfluidics‑based platform that captures and quantifies disease‑specific biomarkers at ultra‑low (femtomolar) concentrations, delivering results within minutes. The system combines highly sensitive detection assays with cost‑effective, scalable chip manufacturing, enabling fast, affordable, and precise testing for early diagnosis in oncology, cardiovascular and infectious diseases. It is targeted at clinical labs, hospital diagnostics and research institutions seeking rapid, high‑sensitivity biomarker analysis.
Funding
Funding not disclosed
Founders
Product
Problem
Current diagnostic tests often lack the sensitivity to detect disease-specific biomarkers at very low concentrations, leading to delayed or missed early diagnoses. Conventional methods can also be slow, expensive, and difficult to scale for widespread clinical use.
Solution
ExoSphere offers a microfluidics‑based platform that captures and quantifies disease‑specific molecules at ultra‑low concentrations, enabling earlier and more reliable detection of conditions such as breast, colorectal, and lung cancer. The system integrates highly sensitive biomarker detection technology with a streamlined workflow that reduces assay time and cost. By leveraging scalable chip fabrication, the platform can be deployed in both research laboratories and routine clinical settings without sacrificing precision. This approach aims to improve patient outcomes by facilitating timely intervention across oncology, cardiovascular, and infectious disease applications.
Target Audience
Primary customers are clinical laboratories, hospital diagnostic departments, and research institutions seeking fast, affordable, and highly sensitive biomarker testing for early disease detection.
Features
- Microfluidic chips that isolate target molecules from minimal sample volumes
- Ultra‑sensitive detection assay capable of measuring biomarkers at femtomolar levels
- Rapid processing workflow delivering results within minutes
- Cost‑effective design optimized for high‑volume manufacturing and deployment
- Modular platform adaptable to a range of disease markers, including oncology, cardiovascular, and infectious diseases
- Integrated data output compatible with standard laboratory information systems